Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/31/2018
12 Central Government Agencies Issues Plan for Generic Drug Supply Sec...
12/30/2018
NMPA Issues Rules for Overseas Inspection of Drugs and Medical Devices
12/30/2018
NMPA Publishes Announcement of Generic Drugs Eligible for Exemptions o...
12/30/2018
NMPA Releases List of Reference Formulations for Generic Drug Equivale...
12/28/2018
IQVIA: Chinese Retail Pharmacy Market Growth Slowed in MAT Q3/2018
12/28/2018
NMPA Issues Announcement Relating to Generic Quality and Clinical Equi...
12/28/2018
NMPA Issues Notice on Strengthening Drug Regulation During Centralized...
12/27/2018
SAMR to Raise Compensation for Flawed Products Endangering Life and He...
12/27/2018
CK: China's Pharma Industry Investment to Reach US$100B in 2019
12/27/2018
JHL Biotech Announces First Patient Randomized in the Phase III Study ...
12/27/2018
NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt (Sintilimab) for Hod...
12/27/2018
India Demands Preferential Treatment of Indian Drugs Approved by Regul...
12/27/2018
Merck KGaA Terminates Partnership with BeiGene for Lifirafenib
12/26/2018
SAMR Issues Amendment of the Provisions for Drug Advertisement Examina...
12/26/2018
CDE Publicizes 36 Drug Applications To Be Granted Priority Review Stat...
12/25/2018
Bayer Suspended by A Leading Military Hospital for Promotional Violati...
12/25/2018
China Issues First Nationwide Negative List, Pledging Equal Treatment ...
12/25/2018
Chinese Government Pledges to Raise Healthcare Investment
12/25/2018
China Removes Import Tariff of 700 Items Including At Least 50+ Drug I...
12/24/2018
China Biotech: Six Things to Watch in 2019
12/24/2018
Draft Patent Law Amendment Under First Review by the NPC (with Key Pha...
12/24/2018
NPC Reviews Draft Foreign Investment Law to Ban Forced Technology Tran...
12/24/2018
NMPA Publishes the Second List of Drugs with Expired, Terminated or In...
12/24/2018
Draft Vaccine Law Submitted to the Chinese Legislature for Review
12/24/2018
NHC: National S&T Major Project for New Drug R&D Harvests Abun...
12/23/2018
Bayer Receives Approval in China for Endometriosis Treatment Visanne
12/23/2018
Recent Executive Moves
12/21/2018
NMPA Issues the Guidelines for Individual ADR Case Collection and Repo...
12/21/2018
SMIA Initiates Process for National DRG Trial
12/20/2018
HitGen and Bayer Enter DNA-Encoded Library Based Research Collaboratio...
Page:
243
/
720
Total number of articles:
21572
:
[First]
[<<]
[241]
[242]
[243]
[244]
[245]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit